eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2024
vol. 20
 
Share:
Share:
Short communication

MicroNET-covered stent ‘sandwich’ technique to seal carotid artery perforation in a highly-calcific lesion

Bogdan Januś
1
,
Wojciech Dziadek
1
,
Julia Kowalewska-Kempa
2
,
Jan Miękisz
3
,
Anna Szwiec
1
,
Jarosław Blicharz
1
,
Zbigniew Cholewa
4
,
Łukasz Tekieli
5, 6
,
Piotr Musialek
5, 6

  1. Department of Cardiology, St. Luke Regional Multispecialty Hospital, Tarnow, Poland
  2. Department of Radiology, St. Luke Regional Multispecialty Hospital, Tarnow, Poland
  3. General and Vascular Surgery Clinic, Diagnostic and Therapeutic Center, Tarnow, Poland
  4. Department of Anesthesia and Intensive Therapy, St. Luke Regional Multispecialty Hospital, Tarnow, Poland
  5. Department of Cardiac and Vascular Diseases, Jagiellonian University, Krakow, Poland
  6. St. John Paul II Hospital, Stroke-Thrombectomy Capable Center, Krakow, Poland
Adv Interv Cardiol 2024; 20, 4 (78): 494–499
Online publish date: 2024/12/31
Article file
- MicroNet.pdf  [0.49 MB]
Get citation
 
 

Whenever reasonably feasible, strokes should be prevented rather than experienced by stroke victims and their families [1, 2]. Despite the progress in medical therapies, atherosclerotic carotid artery stenosis remains an important, mechanistic risk factor of embolic and hemodynamic stroke even in patients on optimized medical therapy [1, 3]. Emerging evidence indicates that with optimized intraprocedural cerebral protection [4] and routine use of sustained embolic prevention stents [5, 6], today’s endovascular (i.e., minimally-invasive) carotid revascularization (carotid artery stenting – CAS) may be, overall, at least as safe and effective as surgery [7]. Although some specific lesion subsets, such as those highly-calcific or thrombus-containing, have been conventionally more challenging for percutaneous carotid or coronary interventions than for surgery, technological progress increasingly facilitates endovascular management of high-risk lesions [4, 6, 810]. This is practically relevant not only for elective CAS (where, to some, surgery remains an alternative) but first of all for emergency CAS because in carotid-related strokes (including tandem strokes) the carotid lesion is mostly highly-thrombotic while in some patients it is also highly-cacific [11].

The decision to perform or defer elective carotid revascularization should ideally be based on a multi-disciplinary (Neuro-Vascular Team) consensus statement [3]. To assist the patient in their decision, the Neuro-Vascular Team may also advise a preferred revascularization mode (according to patient-specific factors and local expertise) [3]. The patient, holding a central position in the decision process regarding their care, requires full information about disease-related stroke risk and treatment options [3].

We would like to share our use of a MicroNET-covered stent-in-stent implantation (‘sandwich’ technique, Figure 1) to seal carotid artery perforation, a rare complication of CAS [12], which occurred during treatment of a highly-calcific carotid lesion in an acute carotid syndrome patient who was rejected from surgery.

Figure 1

Procedural images demonstrating the MicroNET-covered stent ‘sandwich’ technique to seal calcific carotid artery perforation. A is a baseline cerebral angiogram in a 64-year-old male diabetic patient with left internal carotid artery (LICA) chronic total occlusion (CTO; past left-hemispheric stroke, mRS 2) and a symptomatic highly-calcific carotid stenosis on the right (recurrent transient ischemic attacks), cleared by the Neuro-Vascular Team for endovascular management rather than surgery due to severe heart failure, neurologic consequences of prior left hemispheric stroke, and multiple co-morbidities; B shows the right common carotid artery (RCCA) distal non-obstructive diffuse lumen defects and a tandem (yellow arrowheads) stenosis of the right internal carotid artery (RICA) with critical severity in the proximal portion (note projecting calcific nodules); C is a zoomed non-contrast image of the treatment target zone; note massive calcifications forming a calcific “cast” of the index carotid bifurcation (Grade 4 severity of calcifications; circularity index 4 [9]), extending to the proximal right external carotid artery and involving a long segment of RICA (cf., E); D predilatation of the proximal (tight stenosis) portion of the tandem lesion (preceded by placement of a neuroprotective filter in distal RICA – Spider FX 7.0 mm, white arrowhead); initially 3.0 × 12 mm non-compliant (NC) balloon was used, followed by 4.0 × 15 mm NC balloon and 4.5 × 15 mm NC balloon (step-wise carotid calcific lesion preparation as per the PARADIGM Study HCCS Management Protocol [9, 11]); E shows positioning of a MicroNET-covered neuroprotective self-expandable stent (CGuard 9.0 × 40 mm); note that the stent insertion through the distal portion of the tandem required predilating also of the angiographically non-critical distal stenosis; yellow arrowheads denote angiographically-evident calcifications; F is a photograph of the MicroNET-covered stent, consisting of a widely open-cell (area of ~22 mm2, ensuring high adaptability) laser-cut nitinol frame that is wrapped into an embolic prevention MicroNET sleeve (microcell size ~0.02–0.03 mm2) positioned outside the stent frame [18, 19, 21, 22]; G shows post-dilatation optimization of the proximal portion of stented lumen, using a 5.5 × 15 mm NC balloon (arrows denote balloon markers); this step was preceded by sequential embedment of the stent with a 5.0 × 20 mm NC balloon; H is a dye injection demonstrating a focal perforation (red arrowheads) in the mid portion of the stent, causing contrast extravasation; I shows a sealing attempt by performing low-pressure balloon inflations (arrows denote balloon markers); J demonstrates lack of efficacy, in this case, of balloon sealing as the first-line management (red arrowheads point to continued contrast extravasation); note that this angiographic evidence of perforation was accompanied by gradual formation of a neck hematoma; K is implantation of the 2nd MicroNET-covered stent (stentin-stent ‘sandwich’ technique; CGuard 8.0 × 30 mm, white arrowheads) to increase the sealing density effect; this was followed by a gentle balloon inflation to optimize the apposition of the sealing layers; L is a control angiogram demonstrating a reduction – but not yet cessation – of contrast extravasation (red arrowheads); M shows implantation of the 3rd MicroNET-covered stent (CGuard 8.0x30 mm; stent-in-stent-in-stent, white arrowheads) to further maximize the perforation sealing; N is the final balloon inflation for optimized embedment of the 3 (stent + MicroNET) layers; O shows an optimal final angiographic result at the target lesion level of a stenosis-free reconstruction of the target vessel supplying both the right and left cerebral hemisphere; P is the final end-organ angiogram, demonstrating improved cerebral perfusion (white arrowheads, cf., A) in absence of any procedure-related neurologic symptoms

/f/fulltexts/PWKI/55440/PWKI-20-55440-g001_min.jpg

Carotid artery perforation is a rare but serious complication [12, 13]. Emergency management of severe leaks includes external compression (if anatomically feasible) and either surgery (reconstruction or ligation [13]) or endovascular treatment. Conventional endovascular options include carotid artery sacrifice (coiling) to stop bleeding (while risking severe neurologic complications) or perforation sealing with the use of a covered stent (stent-graft) [14, 15]. More recently, effective use of MicroNET-covered stent has been reported in sealing carotid [13] or coronary perforations [16, 17]. The MicroNET-covered carotid stent consists of a widely open-cell (area of ~22 mm2, ensuring high adaptability) laser-cut nitinol frame that is wrapped into embolic prevention [1820]. MicroNET sleeve (microcell size ~0.02–0.03 mm2) positioned outside the stent frame [18, 19, 21, 22].

In minimal-to-moderate leaks, the initial strategy may involve a sealing attempt with prolonged balloon inflations [23]. Prolonged balloon inflations, however, may increase the risk of symptomatic thrombosis, particularly if performed in absence of procedural anticoagulation or with premature (i.e., prior to removal of the interventional devices from the vessel lumen) heparin reversal with protamine [23]. In our patient, protamine reversal of heparin was performed immediately after removal of the filter and guiding catheter from the arterial system.

In contrast to the previously reported [13] effective sealing of perforation in a non-diseased carotid artery with a single MicroNET-covered stent, sealing of the highly-calcific internal carotid artery required creating a layer of 3 MicroNET-covered stents; a new interventional solution (Figure 1). 12-month clinical follow-up was normal, and computed tomography angiography and Duplex ultrasound showed an optimal anatomic and functional effect and, despite the 3 stent + MicroNET layers, with luminal flow normal for a single MicroNET-covered stent and absence of any in-stent restenosis (Figure 2). This is consistent with the MicroNET-covered stent normal healing [22, 2426], and a lasting effect of optimal endovascular reconstruction of carotid artery perforation using a MicroNET-covered stent-in-stent technique, in agreement with a lasting mid-term and long-term effect of MicroNET-covered stent use to restore normal carotid artery lumen in elective stroke prevention and in emergency treatment of carotid-related stroke [11, 22, 2426].

Figure 2

Computed tomography angiography and duplex ultrasound follow-up of CGuard stent-in-stent-instent implantation (3 MicroNET-covered stent layers) to seal perforation a highly-calcific carotid artery. A is computed tomography angiography 3D reconstruction demonstrating, 12 months post-procedure, a full reconstitution of normal anatomy with a normal contrast opacification of the right internal distal carotid artery (RICA) distal to the stent layers; arrowheads mark edges of the outer stent (CGuard 9.0 × 40 mm); RCCA – right common carotid artery, RSA – right subclavian artery; B is a longitudinal section through the RCCA and RICA, demonstrating a normal lumen inside the 3 MicroNET-covered stent layers in RICA and the stent(s) blooming artifact (note also calcium outside the stent(s) layers); the stented segment marked with arrowheads; cf., 1 B–E); C are cross-sectional sequential images of stented RICA/RCCA segment including the distal RICA reference (top; dotted), triple-stent layers, and proximally a single stent layer and the proximal reference (RCCA; dotted); note a more pronounced blooming artifact from the triple than that from a single stent layer; D are control duplex ultrasound images at 12 months, demonstrating an optimal long-term lumen reconstruction with absence of any intraluminal material (top) and a normal flow spectrum (and velocities) as seen in a typical follow-up of single-layer MicroNET-covered stents (cf., Refs [2426])

/f/fulltexts/PWKI/55440/PWKI-20-55440-g002_min.jpg

Besides traumatic injury [13], carotid artery perforation can occur as a complication of carotid artery stenting [12] particularly in case of endovascular management of highly-calcific lesions using the 1st generation (single-layer, non-covered) carotid stents [26]. Intraluminal angioplasty has the potential to cause tearing or rupture of the target vessel; a likely under-reported serious complication. A single-layer nitinol stent is believed, in general, to reinforce the wall of the artery [23]. With angioplasty, the force is transmitted to the circumference of the vessel wall, with only the weakest portion failing [23]. Speculatively, such angioplasty-inflicted tears that may be reinforced by stent placement [23]. Nevertheless, in case of heavy calcification any “aggressive” optimization of a conventional (non-covered) stent may cause perforation [27]. On the other hand, calcification is the most challeging cause for post-procedural residual stenosis – a fundamental factor of in-stent restenosis and stent thrombosis [2830]. Therefore, heavy calcifications have been considered a contraindication to endovascular revascularization using single metallic layer (non-covered) stents [27]. While the MicroNET stent wrap was originally developed to block intraluminal migration of the atherothrombotic plaque material [10, 18, 19, 22], and it was subsequently demonstrated to be effective in this indication [57, 2022], recent analysis from the PARADIGM-101 study suggested efficacy of microNET-covered (CGuard) stent use in optimized endovascular management of highly-calcific carotid artery stenoses [9]. However, it needs to be remembered that the microNET-covered stent is not a stent-graft as it possesses micropores of 150–180 μm [18, 19, 21, 22].

Coiling, an endovascular equivalent of surgical ligation, is associated with a greater stroke risk than that seen with reconstructive techniques that maintain vessel patency and thus ipsilateral cerebral supply [13]. Target artery sacrifice was not considered an option in our patient with a chronic occlusion of the contralateral carotid artery (Figure 1).

Covered stents (stent grafts) were demonstrated to be useful as an effective emergency tool to seal severe perforations (or lesser perforations that persist despite prolonged balloon inflation(s) [23]. However, the risk of in-stent restenosis with fully covered stents (stent grafts) positioned in the carotid location is as high as 15–40% [15, 31], smilar to the restenosis risk occurring with covered stent use in coronary bypass angioplasty [15]. Thus, there is a need for an alternative to exposing patients to such a high restenosis rate. The MicroNET-covered stent, by design, respects carotid anatomy [19, 21, 22], and – when properly embedded – shows a minimal risk of restenosis [5, 22, 2426]. In contrast, covered stents show lack of mechanical flexibility [15, 31] and a prohibitively high (at least in elective use) rate of in-stent restenosis [15]. Furthermore, contrary to typical expectations [28], covered stents fail to prevent lesion-related thrombo-embolism as the embolic material (rather than getting trapped between the stent and the vessel wall) may get squeezed-out and mobilized to blood stream at the covered stent edges [32].

We report effective and uncomplicated sealing of iatrogenic carotid artery perforation using a MicroNET-covered stent ‘sandwich’ technique (Figure 1) with a lasting, optimal angiographic and clinical result (Figure 2). This result is consistent with accumulating evidence for optimal short- and long-term outcomes with the MicroNET-covered stent system in treatment of carotid artery thrombo-atherosclerotic disease in stroke prevention and in acute stroke [5, 11, 2022, 25]. Still, operators should be fully aware that the MicroNET-covered stent system is not fully-covered (i.e., it is not a stent graft). Thus, in case of potential incomplete sealing of the leak with a single MicroNET-covered stent [13] or using the MicroNET-covered stent ‘sandwich’ technique (Figure 1), stent grafts [31] should continue to be available on-shelf for major ruptures that may not be amenable to sealing with the micro-porous MicroNET-covered stent(s). While use of scoring balloons and cutting balloons for calcium rupture more ‘controlled’ than that occurring with non-compliant balloons [8] may increase the safety of highly-calcific carotid lesion CAS [11], use of ultrasonic pulse waves to micro-fracture calcium deposits in the vessel wall (thus turning a non-compliant lesion into a compliant one) is particularly promising [8, 33].

In conclusion, we have demonstrated a safe and effective use of a MicroNET-covered stent system ‘sandwich’ technique to resolve iatrogenic carotid artery perforation of a highly calcific stenosis (Figure 1) in absence of any in-stent restenosis (Figure 2).

Conflict of interest

PM has been proctoring and/or consulting for Abbott Vascular, InspireMD, Medtronic and Penumbra, and he is the Co-Principal Investigator in CGUARDIANS FDA IDE Trial of the MicroNET-covered carotid stent system. Other authors declare no conflict of interest.

References

1 

Musialek P, Rosenfield K, Siddiqui AH, Grunwald IQ. Carotid stenosis and stroke: medicines, stents, surgery-”wait-and-see” or protect? Thromb Haemost 2024; 124: 815-27.

2 

Tekieli L, Dzierwa K, Grunwald IQ, et al. Outcomes in acute carotid-related stroke eligible for mechanical reperfusion: SAFEGUARD-STROKE Registry. J Cardiovasc Surg 2024; 65: 231-48.

3 

Musialek P, Bonati LH, Bulbulia R, et al. Stroke risk management in carotid atherosclerotic disease: a clinical consensus statement of the ESC Council on Stroke and the ESC Working Group on Aorta and Peripheral Vascular Diseases. Cardiovasc Res 2023 Aug 25:cvad135.

4 

Musialek P. Proximal embolic protection with the Mo.Ma Ultra Device: a “must know how” for competent carotid artery stenting. Endovascular Today 2024; 23: 30-2.

5 

Mazurek A, Malinowski K, Rosenfield K, et al.; CARMEN (CArotid Revascularization Systematic Reviews and MEta-aNalyses) Investigators. Clinical outcomes of second- versus first-generation carotid stents: a systematic review and meta-analysis. J Clin Med 2022; 11: 4819.

6 

Musialek P, Langhoff R, Stefanini M, Gray WA. Carotid stent as cerebral protector: the arrival of Godot. J Cardiovasc Surg 2023; 64: 555-60.

7 

Mazurek A, Malinowski K, Sirignano P, et al. CArotid Revascularization systematic reviews and MEta-aNalyses (CARMEN) Collaborators. Carotid artery revascularization using second generation stents versus surgery: a meta-analysis of clinical outcomes. J Cardiovasc Surg 2023; 64: 570-82.

8 

Dawood M, Elwany M, Abdelgawad H, et al. Coronary calcifications, the Achilles heel in coronary interventions. Adv Interv Cardiol 2024; 20: 1-17.

9 

Mazurek A, Partyka L, Trystula M, et al. Highly-calcific carotid lesions endovascular management in symptomatic and increased-stroke-risk asymptomatic patients using the CGuard dual-layer carotid stent system: analysis from the PARADIGM study. Catheter Cardiovasc Interv 2019; 94: 149-56.

10 

Musialek P, Roubin GS. Double-layer carotid stents: from the clinical need, through a stent-in-stent strategy, to effective plaque isolation… the Journey Toward Safe Carotid Revascularization Using the Endovascular Route. J Endovasc Ther 2019; 26: 572-7.

11 

Tekieli L, Afanasjev A, Mazgaj M, et al. A multi-center study of the MicroNET-covered stent in consecutive patients with acute carotid-related stroke: SAFEGUARD-STROKE. Adv Interv Cardiol 2024; 20: 172-93.

12 

Nicosia A, Nikas D, Castriota F, et al. Classification for carotid artery stenting complications: manifestation, management, and prevention. J Endovasc Ther 2010; 17: 275-94.

13 

Lehmann MF, Musialek P. MicroNET-covered stent use to seal carotid artery perforation. Adv Interv Cardiol 2023; 19: 284-8.

14 

Dieter RS, Ikram S, Satler LF, et al. Perforation complicating carotid artery stenting: the use of a covered stent. Catheter Cardiovasc Interv 2006; 67: 972-5.

15 

Murarka S, Hatler C, Heuser RR. Polytetrafluoroethylene-covered stents: 15 years of hope, success and failure. Expert Rev Cardiovasc Ther 2010; 8: 645-50.

16 

Fogarassy G, Apró D, Veress G. Successful sealing of a coronary artery perforation with a mesh-covered stent. J Invasive Cardiol 2012; 24: E80-3.

17 

Romaguera R, Gomez-Hospital JA, Cequier A. Novel use of the MGuard mesh-covered stent to treat coronary arterial perforations. Catheter Cardiovasc Interv 2012; 80: 75-8.

18 

Schofer J, Musialek P, Bijuklic K, et al. A prospective, multicenter study of a novel mesh-covered carotid stent: the CGuard CARENET Trial (Carotid Embolic Protection Using MicroNet). JACC Cardiovasc Interv 2015; 8: 1229-34.

19 

Wissgott C, Schmidt W, Brandt-Wunderlich C, et al. Clinical results and mechanical properties of the carotid CGUARD double-layered embolic prevention stent. J Endovasc Ther 2017; 24: 130-7.

20 

Karpenko A, Bugurov S, Ignatenko P, et al. Randomized controlled trial of conventional versus MicroNet-covered stent in carotid artery revascularization. JACC Cardiovasc Interv 2021; 14: 2377-87.

21 

Musialek P, Mazurek A, Trystula M, et al. Novel PARADIGM in carotid revascularisation: prospective evaluation of All-comer peRcutaneous cArotiD revascularisation in symptomatic and Increased-risk asymptomatic carotid artery stenosis using CGuard™ MicroNet-covered embolic prevention stent system. EuroIntervention 2016; 12: e658-70.

22 

Musialek P, Tekieli L, Umemoto T. Carotid antiembolic (“Mesh”) stents: not created equal. J Soc Cardiovasc Angiogr Interv 2024; 3: 102429.

23 

Broadbent LP, Moran CJ, Cross DT 3rd, Derdeyn CP. Management of ruptures complicating angioplasty and stenting of supraaortic arteries: report of two cases and a review of the literature. AJNR Am J Neuroradiol 2003; 24: 2057-61.

24 

Mazurek A, Borratynska A, Malinowski KP, et al. MicroNET-covered stents for embolic prevention in patients undergoing carotid revascularisation: twelve-month outcomes from the PARADIGM study. EuroIntervention 2020; 16: e950-2.

25 

Karpenko A, Bugurov S, Ignatenko P, et al. Randomized controlled trial of conventional versus MicroNet-covered stent in carotid artery revascularization: 12-month outcomes. JACC Cardiovasc Interv 2023; 16: 878-80.

26 

Musialek P, Mazurek A, Kolvenbach R, et al. 5-year clinical and ultrasound outcomes in CARENET prospective multicenter trial of CGuard MicroNET-covered carotid stent. JACC Cardiovasc Interv 2022; 15: 1889-91.

27 

Bates ER, Babb JD, Casey DE, et al. ACCF/SCAI/SVMB/SIR/ASITN clinical expert consensus document on carotid stenting. J Am Coll Cardiol 2007; 49: 126-70.

28 

Cosottini M, Michelassi MC, Bencivelli W, et al. In stent restenosis predictors after carotid artery stenting. Stroke Res Treat 2010; 2010: 864724.

29 

Kang J, Hong JH, Kim BJ, et al. Residual stenosis after carotid artery stenting: Effect on periprocedural and long-term outcomes. PLoS One 2019; 14: e0216592.

30 

Lai PMR, Baig AA, Khawar WI, et al. Residual in-stent carotid stenosis and cigarette smoking are independent predictors of carotid restenosis after carotid artery stenting-results from 738 carotid artery stenting procedures at a single center. Neurosurgery 2023 [e-pub ahead of print].

31 

Schillinger M, Dick P, Wiest G, et al. Covered versus bare self-expanding stents for endovascular treatment of carotid artery stenosis: a stopped randomized trial. J Endovasc Ther 2006; 13: 312-9.

32 

Blackman DJ, Choudhury RP, Banning AP, Channon KM. Failure of the Symbiot PTFE-covered stent to reduce distal embolization during percutaneous coronary intervention in saphenous vein grafts. J Invasive Cardiol 2005; 17: 609-12.

33 

Singh J, Kuhn AL, Massari F, et al. Intravascular lithotripsy for severely calcified carotid artery stenosis – a new frontier in carotid artery stenting? Interv Neuroradiol 2023; 29: 768-72.

Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2025 Termedia Sp. z o.o.
Developed by Bentus.